200 related articles for article (PubMed ID: 3055700)
21. [Effect of tamoxifen on the content of cytoplasmic steroid hormone receptors of the tumor in patients with cancer of the corpus uteri].
Tsyrlina EV; Sofroniĭ DF; Dil'man VM; Bokhman IaV; Vishnevskiĭ AS
Vopr Onkol; 1989; 35(6):675-80. PubMed ID: 2750079
[TBL] [Abstract][Full Text] [Related]
22. [Expression of estrogen and progesterone receptors and oncoprotein HER-2 as a marker for clinical course and outcome in endometrioid adenocarcinoma of the uterine body (immunohistologic study)].
Samsonova EA; Maksimova NA; Urmancheeva AF; Pozharisskiĭ KM
Vopr Onkol; 2004; 50(2):196-201. PubMed ID: 15176223
[TBL] [Abstract][Full Text] [Related]
23. Sex steroid receptors in gynecologic cancer.
Hoffman PG; Siiteri PK
Obstet Gynecol; 1980 May; 55(5):648-52. PubMed ID: 6988749
[TBL] [Abstract][Full Text] [Related]
24. Elastosis in human breast cancer. Correlation with sex steroid receptors and comparison with clinical outcome.
Glaubitz LC; Bowen JH; Cox EB; McCarty KS
Arch Pathol Lab Med; 1984 Jan; 108(1):27-30. PubMed ID: 6546333
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
[TBL] [Abstract][Full Text] [Related]
26. Influence of "nuclear" estrogen receptor content on prognosis of early stage carcinoma of the uterine body. A short-time follow-up.
Horvath G; Johnsson JE; Tropé C; Samuelsson L; Alm P; Olsson H
Neoplasma; 1990; 37(1):43-6. PubMed ID: 2320180
[TBL] [Abstract][Full Text] [Related]
27. [The level of steroid hormone receptors in endometrial cancer].
Bieglmayer C; Spona J; Ulm R; Husslein P
Acta Univ Palacki Olomuc Fac Med; 1981; 101():159-65. PubMed ID: 6211045
[No Abstract] [Full Text] [Related]
28. [Steroid hormone receptor level in endometrial carcinoma].
Bieglmayer C; Spona J; Ulm R; Husslein P
Acta Univ Palacki Olomuc Fac Med; 1981; 101():159-65. PubMed ID: 6242688
[No Abstract] [Full Text] [Related]
29. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
Ehrlich CE; Young PC; Stehman FB; Sutton GP; Alford WM
Am J Obstet Gynecol; 1988 Apr; 158(4):796-807. PubMed ID: 2966586
[TBL] [Abstract][Full Text] [Related]
30. Identification of endocrine responsive breast and endometrial carcinoma using steroid hormone receptors.
Wittliff JL; Day TG; Dean WL; Allegra JC
Prog Clin Biol Res; 1988; 276():11-41. PubMed ID: 3051018
[No Abstract] [Full Text] [Related]
31. [Results of assays of estrogen, progesterone and androgen receptors in stage I and II adenocarcinoma of the endometrium].
Cormier P; Floquet A; Wafflart J; Coindre JM; Bonichon F; Marée D
Rev Fr Gynecol Obstet; 1991; 86(7-9):491-4. PubMed ID: 1754802
[TBL] [Abstract][Full Text] [Related]
32. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas.
Soper JT; McCarty KS; Hinshaw W; Creasman WT; McCarty KS; Clarke-Pearson DL
Am J Obstet Gynecol; 1984 Oct; 150(4):342-8. PubMed ID: 6486200
[TBL] [Abstract][Full Text] [Related]
34. Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma.
Creasman WT; McCarty KS; Barton TK; McCarty KS
Obstet Gynecol; 1980 Mar; 55(3):363-70. PubMed ID: 7189047
[TBL] [Abstract][Full Text] [Related]
35. [Cytoplasmic steroid hormone receptors in primary breast tumors].
Bassalyk LS; Murav'eva NI; Smirnova KD; Kuz'mina ZV; Vishniakova VV
Vopr Onkol; 1982; 28(4):6-10. PubMed ID: 7090272
[TBL] [Abstract][Full Text] [Related]
36. Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
Anticancer Res; 2003; 23(1B):729-32. PubMed ID: 12680175
[TBL] [Abstract][Full Text] [Related]
37. [Estrogen and progesterone receptor assay in the normal endometrium and endometrial carcinoma].
Li SY
Zhonghua Zhong Liu Za Zhi; 1984 Nov; 6(6):429-31. PubMed ID: 6532745
[No Abstract] [Full Text] [Related]
38. Are cytosol estrogen and progestin receptors of prognostic significance in the management of epithelial ovarian cancers?
Schwartz PE; MacLusky N; Merino MJ; Livolsi VA; Kohorn EI; Eisenfeld A
Obstet Gynecol; 1986 Dec; 68(6):751-8. PubMed ID: 3785785
[TBL] [Abstract][Full Text] [Related]
39. [Correlation between estrogen receptor(ER), progesterone receptor(PR) and human keratin protein (hKP) in endometrial carcinoma].
Hatae M; Yagi Y
Gan No Rinsho; 1983 Dec; 29(15):1740-9. PubMed ID: 6199529
[TBL] [Abstract][Full Text] [Related]
40. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].
Backe J; Gassel AM; Müller T; Schön S; Kaesemann H
Zentralbl Gynakol; 1997; 119(7):334-42. PubMed ID: 9340973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
